Enhanced Metal Reduction Techniques for Definitive CT Scanning to Assess Spinal Fusion With TM-Ardis
NCT ID: NCT02170558
Last Updated: 2019-01-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2014-06-30
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Post-Market Surveillance Study of the TM Ardis Interbody Fusion System
NCT02429908
Spine Research With Roentgen Stereophotogrammetric Analysis
NCT00493558
Pilot Study of rhBMP/BCP With or Without the TSRH® Spinal System for Posterolateral Lumbar Fusion in Patients With Degenerative Disc Disease
NCT01494441
Clinical and Radiological Evaluation of Patients With DDD Following TLIF With 3-D Printed Titanium Cage
NCT03018392
Evaluate Effectiveness of the Biomet Lumbar Spinal Fusion System
NCT00758719
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients implanted w/TM-Ardis
Patients who are receiving a TM-Ardis implant for degenerative disc disease will have a CT scan immediate post op (2 weeks) and again at 6 months to determine if fusion can be assessed with the study metal reduction software. Will utilize TM- Ardis implant and Metal Reduction CT software
TM- Ardis implant and Metal Reduction CT software
TM- Ardis implant and Metal Reduction CT software
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TM- Ardis implant and Metal Reduction CT software
TM- Ardis implant and Metal Reduction CT software
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Male or non-pregnant female scheduled for Trabecular Metal (TM - Ardis) implant, single level lumbar.
* Participant must be at least 18 years of age.
Exclusion Criteria
* Patient is unable to undergo scanning (due to body habitus, inability to comply with positioning requirements, etc.).
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zimmer Biomet
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joel Batts
Role: STUDY_DIRECTOR
Zimmer Biomet Spine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St Alphonsus Regional Medical Center
Boise, Idaho, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CSU2013-05S
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.